These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30047547)
1. Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer. Yang J; Tang H; Huang J; An H Med Sci Monit; 2018 Jul; 24():5185-5191. PubMed ID: 30047547 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer. Wu W; Qian L; Chen X; Ding B Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer. Zhang X; Wang Y; Ning Y Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181 [TBL] [Abstract][Full Text] [Related]
5. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis. Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490 [No Abstract] [Full Text] [Related]
6. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells. Qiao N; Wang L; Wang T; Li H Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570 [TBL] [Abstract][Full Text] [Related]
8. The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner. Birner P; Tchorbanov A; Natchev S; Tuettenberg J; Guentchev M J Clin Pathol; 2015 Oct; 68(10):830-4. PubMed ID: 26109200 [TBL] [Abstract][Full Text] [Related]
9. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma. Liu Z; Teng XY; Meng XP; Wang BS World J Surg Oncol; 2014 Nov; 12():348. PubMed ID: 25407240 [TBL] [Abstract][Full Text] [Related]
10. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer. Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252 [TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance. Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500 [TBL] [Abstract][Full Text] [Related]
12. Zhou J; Yang X; Song P; Wang H; Wang X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305 [No Abstract] [Full Text] [Related]
13. Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways. Li XX; Zheng HT; Huang LY; Shi DB; Peng JJ; Liang L; Cai SJ Int J Oncol; 2014 Oct; 45(4):1649-57. PubMed ID: 25051350 [TBL] [Abstract][Full Text] [Related]
14. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway. Li N; Xu H; Ou Y; Feng Z; Zhang Q; Zhu Q; Cai Z Diagn Pathol; 2019 Jan; 14(1):3. PubMed ID: 30636642 [TBL] [Abstract][Full Text] [Related]
15. Elevated CISD2 expression predicts poor diagnosis and promotes invasion and migration of prostate cancer cells. Zhu QQ; Tian L; Li DL; Wu ZH; He YY; Zhang HK Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6597-6604. PubMed ID: 32633348 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways. Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680 [TBL] [Abstract][Full Text] [Related]
19. Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients. Lu J; Sun P; Sun B; Wang C Med Sci Monit; 2015 Nov; 21():3722-7. PubMed ID: 26616116 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer. Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]